CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)

In the UK, death from heart failure (HF) is at 24,000 in 2001, while new cases of HF is estimated to be at 63,500 every year. The probability of death within one year of diagnosis is 40%, if untreated (1). Heart failure treatment varies from lifestyle change, pharmacological treatment or surgical in...

Full description

Bibliographic Details
Main Authors: Khudzari, Zahran, Richens, D., Tansley, G. D.
Format: Article
Published: 2010
Subjects:
_version_ 1796855977125871616
author Khudzari, Zahran
Richens, D.
Tansley, G. D.
author_facet Khudzari, Zahran
Richens, D.
Tansley, G. D.
author_sort Khudzari, Zahran
collection ePrints
description In the UK, death from heart failure (HF) is at 24,000 in 2001, while new cases of HF is estimated to be at 63,500 every year. The probability of death within one year of diagnosis is 40%, if untreated (1). Heart failure treatment varies from lifestyle change, pharmacological treatment or surgical intervention. For advanced stages HF patients, heart transplant is the gold standard treatment. However, since donors are scarce resulting only 3000 operation/year worldwide, the next best treatment is mechanical heart assist device. The aim of this study is to develop mechanical heart assist device specifically for left ventricle i.e. left ventricular assist device (LVAD) system that is able to restore heart health by reverse remodelling (self healing process). It is hypothesized reverse remodelling can be achieved by decreasing load faced by heart and increasing coronary perfusion.
first_indexed 2024-03-05T18:36:35Z
format Article
id utm.eprints-22960
institution Universiti Teknologi Malaysia - ePrints
last_indexed 2024-03-05T18:36:35Z
publishDate 2010
record_format dspace
spelling utm.eprints-229602018-11-30T06:22:42Z http://eprints.utm.my/22960/ CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD) Khudzari, Zahran Richens, D. Tansley, G. D. T Technology (General) In the UK, death from heart failure (HF) is at 24,000 in 2001, while new cases of HF is estimated to be at 63,500 every year. The probability of death within one year of diagnosis is 40%, if untreated (1). Heart failure treatment varies from lifestyle change, pharmacological treatment or surgical intervention. For advanced stages HF patients, heart transplant is the gold standard treatment. However, since donors are scarce resulting only 3000 operation/year worldwide, the next best treatment is mechanical heart assist device. The aim of this study is to develop mechanical heart assist device specifically for left ventricle i.e. left ventricular assist device (LVAD) system that is able to restore heart health by reverse remodelling (self healing process). It is hypothesized reverse remodelling can be achieved by decreasing load faced by heart and increasing coronary perfusion. 2010 Article PeerReviewed Khudzari, Zahran and Richens, D. and Tansley, G. D. (2010) CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD). International Journal of Artificial Organs, 33 (7). 473 - 473. https://research.aston.ac.uk/portal/files/235090/Macedonian_Poster_-_F.pdf
spellingShingle T Technology (General)
Khudzari, Zahran
Richens, D.
Tansley, G. D.
CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)
title CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)
title_full CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)
title_fullStr CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)
title_full_unstemmed CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)
title_short CIMS balloon pump : A Novel Left Ventricle Assist Device (LVAD)
title_sort cims balloon pump a novel left ventricle assist device lvad
topic T Technology (General)
work_keys_str_mv AT khudzarizahran cimsballoonpumpanovelleftventricleassistdevicelvad
AT richensd cimsballoonpumpanovelleftventricleassistdevicelvad
AT tansleygd cimsballoonpumpanovelleftventricleassistdevicelvad